Beta-lactam + Beta-lactamase Inhibitor · General Range · AZOT
TEXAMOXY-CV-625
Amoxicillin 500mg + Clavulanic Acid 125mg Tablet
First-line oral antibiotic combination for common community-acquired bacterial infections — AZOT marketing division.
At a Glance
Product Specifications
| Brand Name | TEXAMOXY-CV-625 |
|---|---|
| Generic / Composition | Amoxicillin (as trihydrate) IP 500mg + Clavulanic Acid (as potassium clavulanate) IP 125mg |
| Therapeutic Category | Beta-lactam + Beta-lactamase Inhibitor |
| Dosage Form | Film-coated tablet |
| Strength | 625mg (500mg + 125mg) |
| Route of Administration | Oral |
| Pack Size | Strip of 10 tablets |
| Storage | Store below 25°C in a dry place. Protect from moisture. |
| Manufacturer | Biofril Healthcare Pvt. Ltd. · WHO-GMP Plant, Nalagarh HP |
| Prescription Status | Rx — To be sold by retail on the prescription of a Registered Medical Practitioner |
Clinical Use
Indications & Clinical Applications
TEXAMOXY-CV-625 is indicated for the treatment of common bacterial infections in adults and children.
- Acute bacterial sinusitis
- Community-acquired pneumonia
- Acute otitis media
- Skin and soft tissue infections (including animal/human bites)
- UTI
- Acute exacerbation of chronic bronchitis
Why Biofril TEXAMOXY-CV-625
Product Features
- Clavulanic acid restores activity against beta-lactamase producers
- Twice-daily dosing improves compliance
- AZOT brand for PCD distribution
- WHO-GMP manufactured
Safety
Warnings & Precautions
Contraindicated in penicillin allergy and history of clavulanate-associated cholestatic jaundice. Use with caution in renal impairment, hepatic disease. Monitor for C. difficile diarrhoea, anaphylaxis. Risk of skin rash in infectious mononucleosis.
This information is intended for healthcare professionals. Always consult complete product insert and a registered medical practitioner. Report adverse events to biofrilhealthcare@gmail.com.
Enquire About TEXAMOXY-CV-625
PCD franchise · Hospital tenders · Bulk supply